E-LIB Suche - Ergebnisse für: Barucha, Anton

1

Scoring Abdominal Symptoms in People with Cystic Fibrosis:

Tabori, Harold ; Barucha, Anton ; Zagoya, Carlos...
Journal of Clinical Medicine. 13 (2024) 6 - p. 1650 , 2024

Link: https://doi.org/10.3390/..

2

Reduction in abdominal symptoms (CFAbd-Score), faecal M2-py..:

Mainz, Jochen G. ; Lester, Karen ; Elnazir, Basil...
Journal of Cystic Fibrosis. 23 (2024) 3 - p. 474-480 , 2024

Link: https://doi.org/10.1016/..

3

Dynamics of abdominal symptoms during the start of a new th..:

Mainz, Jochen G. ; Barucha, Anton ; Huang, Pu...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment red..:

Mainz, Jochen G. ; Zagoya, Carlos ; Polte, Louise...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdomina..:

Mainz, Jochen G. ; Zagoya, Carlos ; Polte, Louise...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibr..:

Tabori, Harold ; Schneider, Jochen ; Lüth, Stefan...
International Journal of Molecular Sciences. 23 (2022) 20 - p. 12436 , 2022

Link: https://doi.org/10.3390/..

7

Antibody response against Pseudomonas aeruginosa and its re..:

Mauch, Renan M. ; Hentschel, Julia ; Aanaes, Kasper...
Pediatric Pulmonology. 55 (2020) 4 - p. 959-967 , 2020

Link: https://doi.org/10.1002/..

8

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment red..:

Mainz, Jochen G ; Zagoya, Carlos ; Polte, Louise...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189544/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdomina..:

Mainz, Jochen G ; Zagoya, Carlos ; Polte, Louise...
https://repository.publisso.de/resource/frl:6438598. , 2022

Link: https://repository.publi..

10

Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibr..:

Tabori, Harold ; Schneider, Jochen ; Lüth, Stefan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603931/. , 2022

Link: http://www.ncbi.nlm.nih...

11

DataSheet1_Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduc..:

Jochen G. Mainz ; Carlos Zagoya ; Louise Polte...
doi:10.3389/fphar.2022.877118.s001. , 2023

Link: https://doi.org/10.3389/..

12

Dynamics of abdominal symptoms during the start of a new th..:

Jochen G. Mainz ; Anton Barucha ; Pu Huang...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1167407/full. , 2023

Link: https://doi.org/10.3389/..

13

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment red..:

Jochen G. Mainz ; Carlos Zagoya ; Louise Polte...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1207356/full. , 2023

Link: https://doi.org/10.3389/..

14

Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibr..:

Harold Tabori ; Jochen Schneider ; Stefan Lüth...
Molecular Biology. , 2022

Link: https://doi.org/10.3390/..

15

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdomina..:

Jochen G. Mainz ; Carlos Zagoya ; Louise Polte...
https://www.frontiersin.org/articles/10.3389/fphar.2022.877118/full. , 2022

Link: https://doi.org/10.3389/..